Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hidekazu Shirota

Showing results (71-80 of 90) with videos related to

Pageof 9
Sort By:
International Journal of Clinical Oncology|March 8, 2018
Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumorsKota Ouchi, Shin Takahashi, Sonoko Chikamatsu, et al.
Plos One|June 23, 2017
The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional studyMasahiro Takahashi, Masanobu Takahashi, Keigo Komine, et al.
Blood|October 26, 2010
A novel role for IL-22R1 as a driver of inflammationRam Savan, Adelle P McFarland, Della A Reynolds, et al.
Anticancer Research|March 29, 2022
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 TrialTakashi Yoshioka, Masanobu Takahashi, Yasuhiro Sakamoto, et al.
The Tohoku Journal of Experimental Medicine|June 26, 2018
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisAkira Okita, Hiroo Imai, Masahiro Takahashi, et al.
Eclinicalmedicine|February 9, 2024
Dabrafenib and trametinib administration in patients with <i>BRAF</i> V600E/R or non-V600 <i>BRAF</i> mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trialTatsunori Shimoi, Kuniko Sunami, Makoto Tahara, et al.
Toxins|July 2, 2021
Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian CancerEiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.
Cancer Medicine|October 17, 2022
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational studyHidekazu Shirota, Keigo Komine, Masanobu Takahashi, et al.
Journal of Human Genetics|February 22, 2023
Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facilityMaako Kawamura, Hidekazu Shirota, Tetsuya Niihori, et al.
Familial Cancer|February 3, 2026
Attenuated Li-Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case reportYuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, et al.
Pageof 9

Showing results (71-80 of 90) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Oncology|March 8, 2018
Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumorsKota Ouchi, Shin Takahashi, Sonoko Chikamatsu, et al.
Plos One|June 23, 2017
The G8 screening tool enhances prognostic value to ECOG performance status in elderly cancer patients: A retrospective, single institutional studyMasahiro Takahashi, Masanobu Takahashi, Keigo Komine, et al.
Blood|October 26, 2010
A novel role for IL-22R1 as a driver of inflammationRam Savan, Adelle P McFarland, Della A Reynolds, et al.
Anticancer Research|March 29, 2022
Cisplatin Plus Capecitabine After Adjuvant S-1 in Metastatic Gastric Cancer: A Phase II T-CORE1102 TrialTakashi Yoshioka, Masanobu Takahashi, Yasuhiro Sakamoto, et al.
The Tohoku Journal of Experimental Medicine|June 26, 2018
Efficacy and Safety of Trastuzumab in Combination with S-1 and Cisplatin Therapy for Japanese Patients with HER2-Positive Advanced Gastric Cancer: Retrospective AnalysisAkira Okita, Hiroo Imai, Masahiro Takahashi, et al.
Eclinicalmedicine|February 9, 2024
Dabrafenib and trametinib administration in patients with <i>BRAF</i> V600E/R or non-V600 <i>BRAF</i> mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trialTatsunori Shimoi, Kuniko Sunami, Makoto Tahara, et al.
Toxins|July 2, 2021
Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian CancerEiji Hishinuma, Muneaki Shimada, Naomi Matsukawa, et al.
Cancer Medicine|October 17, 2022
Clinical decisions by the molecular tumor board on comprehensive genomic profiling tests in Japan: A retrospective observational studyHidekazu Shirota, Keigo Komine, Masanobu Takahashi, et al.
Journal of Human Genetics|February 22, 2023
Management of patients with presumed germline pathogenic variant from tumor-only genomic sequencing: A retrospective analysis at a single facilityMaako Kawamura, Hidekazu Shirota, Tetsuya Niihori, et al.
Familial Cancer|February 3, 2026
Attenuated Li-Fraumeni syndrome with TP53 p.R181H in a Japanese patient with metastatic rectal adenocarcinoma: a case reportYuki Kasahara, Masanobu Takahashi, Yoshifumi Kawamura, et al.
Pageof 9